multiple studies that shows the efficacy of Chelation Therapy.

[Guest guest]

There are multiple studies that shows the efficacy of Chelation

Therapy. Here is one such study from the Journal of Integrative

Medicine...

 

Journal of Integrative Medicine 1997;1:7-12

 

Improved Myocardial Perfusion in Patients with Advanced Ischemic

Heart Disease with An Integrative Management Program Including

EDTA Chelation Therapy

 

Majid Ali, M.D., Omar Ali, M.D., Alfred Fayemi, M.D., Judy Juco,

M.D.,

Carol Grieder-Brandenburger, R.N.

 

From the Departments of Medicine of Capital University of Integrative

Medicine, Washington, D.C., and Institute of Preventive Medicine, New

York (MA,OA,AF,JJ, CG), the Department of Pathology, College of

Physicians and Surgeons, Columbia University, New York (MA), and

Department of Pathology, Mount Sinai School of Medicine (AF). Send

requests for reprints to MA at Suite 1-H, 140 West End Avenue, New

York, N.Y. 10083. This outcome study was presented in part at the

1995 annual meeting of the American Academy of Preventive Medicine in

New York.

 

Objective

To assess the clinical efficacy of an integrated management

program including nutritional and herbal therapies, nongoal-oriented

exercise, self- regulation, and EDTA chelation therapy for patients

with advanced ischemic heart disease (IHD).

 

Patients

Twenty-six consecutive patients who presented with advanced

ischemic heart disease and who had fared poorly after one or more

coronary bypass operations (5), one or more angioplasty procedures

(6), or who failed to respond adequately to multiple drug therapies

(15), and who had received a minimum number of 20 EDTA infusions.

Duration of follow-up ranged from 15 months to 9 years.

 

Methods

1. Clinical evaluation of patients before, during and after the

integrated program used in this study. 2. Assessment of myocardial

perfusion by comparative study of thallium perfusion scans performed

before and after the IHD reversal program.

 

Clinical Outcome Measures

The following clinical outcome criteria were semiquantitatively

defined: Excellent outcome, absence of significant symptoms and

discontinuance of previously prescribed drug therapies; good, 75%+

relief of symptoms and reduction of drug dose; moderate, 50%+ relief

of symptoms and reduction of drug dose; and poor, 25% or less relief

of symptoms and reduction of drug dosage. Elements for follow-up

included in the clinical outcome sheet were as follows: angina, chest

tightness and related discomfort, arrhythmia, other chest symptoms,

dyspnea, severity of stress, mood changes, anger, energy level,

quality of sleep, appetite, digestion and frequency of bowel

movements (all clinical parameters that determine the degree of AA

oxidopathy—a state of chronic and insidious accelerated oxidative

molecular injury to all elements of the circulating blood which we

consider to be the core pathogenetic mechanism of IHD.1)

 

Results

Clinical outcome data are as follows: excellent 61%, good 17%,

moderate 13%, and poor 9%. Comparative study of pre- and post-

chelation myocardial perfusion scans showed clear, objective evidence

of significant improvement in myocardial perfusion in five of six

patients in whom such studies were performed. No patients during the

study period suffered an acute myocardial infarction or underwent

angioplasty or coronary bypass operation.

 

Conclusion

Preliminary and limited outcome data in this study indicate

significant potential for reversing IHD in patients with advanced

ischemic heart disease by an integrated management plan with global

emphasis on reducing oxidative stress on the circulating blood,

cardiac myocytes and the conducting system of the heart. The program

included nutritional and herbal therapies, self-regulation, nongoal-

oriented exercise and EDTA chelation therapy. Additional and larger

studies are warranted to fully explore the clinical potential of such

an integrated management plan.

 

www.majidali.com/edta.htm (full bibliography in link)